State Street Corp Harvard Bioscience Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Harvard Bioscience Inc stock. As of the latest transaction made, State Street Corp holds 717,387 shares of HBIO stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
717,387
Previous 709,624 1.09%
Holding current value
$1.64 Million
Previous $2.02 Million 4.6%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.64 - $3.54 $20,494 - $27,481
7,763 Added 1.09%
717,387 $1.93 Million
Q2 2024

Aug 14, 2024
BUY
$2.77 - $4.63 $45,414 - $75,908
16,395 Added 2.37%
709,624 $2.02 Million
Q1 2024

May 15, 2024
BUY
$4.02 - $5.39 $43,440 - $58,244
10,806 Added 1.58%
693,229 $2.94 Million
Q4 2023

Feb 14, 2024
BUY
$4.0 - $5.49 $57,388 - $78,765
14,347 Added 2.15%
682,423 $3.65 Million
Q3 2023

Nov 14, 2023
BUY
$4.0 - $5.82 $164,784 - $239,760
41,196 Added 6.57%
668,076 $2.87 Million
Q2 2023

Aug 14, 2023
BUY
$4.19 - $6.16 $2.09 Million - $3.08 Million
499,328 Added 391.47%
626,880 $3.44 Million
Q2 2022

Aug 15, 2022
SELL
$3.28 - $6.42 $2.02 Million - $3.95 Million
-615,377 Reduced 82.83%
127,552 $459,000
Q1 2022

May 16, 2022
BUY
$5.16 - $7.14 $202,137 - $279,702
39,174 Added 5.57%
742,929 $4.61 Million
Q4 2021

Feb 14, 2022
BUY
$6.37 - $8.18 $115,042 - $147,730
18,060 Added 2.63%
703,755 $4.96 Million
Q3 2021

Nov 15, 2021
SELL
$6.98 - $8.47 $12,584 - $15,271
-1,803 Reduced 0.26%
685,695 $4.79 Million
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $497,564 - $768,297
91,464 Added 15.35%
687,498 $5.73 Million
Q1 2021

May 17, 2021
SELL
$3.91 - $6.99 $159,054 - $284,346
-40,679 Reduced 6.39%
596,034 $3.25 Million
Q4 2020

Feb 16, 2021
BUY
$3.0 - $4.5 $517,164 - $775,746
172,388 Added 37.13%
636,713 $2.73 Million
Q3 2020

Nov 10, 2020
BUY
$2.75 - $4.2 $127,781 - $195,157
46,466 Added 11.12%
464,325 $1.4 Million
Q2 2020

Aug 14, 2020
BUY
$2.12 - $3.14 $861,568 - $1.28 Million
406,400 Added 3546.56%
417,859 $1.3 Million
Q1 2020

May 11, 2020
BUY
$1.42 - $3.29 $16,271 - $37,700
11,459 New
11,459 $25,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $95.3M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email